Literature DB >> 20354549

Urinary liver fatty acid-binding protein: another novel biomarker of acute kidney injury.

Blaithin A McMahon1, Patrick Thomas Murray.   

Abstract

Liver fatty acid-binding protein (L-FABP) binds selectively to intracellular free unsaturated fatty acids and lipid peroxidation products during hypoxic tissue injury. Urinary L-FABP is a potential biomarker for the detection and assessment of acute kidney injury (AKI). Ferguson et al. have demonstrated in a cross-sectional study that urinary L-FABP is an excellent biomarker of AKI and may be useful in predicting dialysis-free survival. This study did not assess utility for early diagnosis of AKI.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20354549     DOI： 10.1038/ki.2010.5

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  11 in total

1.  Section 3: Prevention and Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

2.  [Values of combination of urinary L-FABP and NGAL in early diagnosis of acute kidney injury after cardiac surgery in children].

Authors:  Rong Tang; Xiang Ao; Yong Zhong; Rui-Ling Wang; Qiao-Ling Zhou
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-07

3.  Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes.

Authors:  Yakov M Koen; Diganta Sarma; Todd D Williams; Nadezhda A Galeva; R Scott Obach; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2012-04-10       Impact factor: 3.739

4.  Proteomic Analysis of Urine from California Sea Lions ( Zalophus californianus): A Resource for Urinary Biomarker Discovery.

Authors:  Benjamin A Neely; Katherine C Prager; Alison M Bland; Christine Fontaine; Frances M Gulland; Michael G Janech
Journal:  J Proteome Res       Date:  2018-08-28       Impact factor: 4.466

5.  Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis.

Authors:  Paweena Susantitaphong; Monchai Siribamrungwong; Kent Doi; Eisei Noiri; Norma Terrin; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2012-12-08       Impact factor: 8.860

6.  Cardiorenal syndromes: pathophysiology to prevention.

Authors:  Peter A McCullough
Journal:  Int J Nephrol       Date:  2010-12-01

Review 7.  Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.

Authors:  Carole G Campion; Oraly Sanchez-Ferras; Sri N Batchu
Journal:  Can J Kidney Health Dis       Date:  2017-05-22

8.  Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.

Authors:  Kuei-Mei Chou; Chin-Chan Lee; Chih-Huang Chen; Chiao-Yin Sun
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

Review 9.  Biomarkers of Renal Disease and Progression in Patients with Diabetes.

Authors:  Radovan Hojs; Robert Ekart; Sebastjan Bevc; Nina Hojs
Journal:  J Clin Med       Date:  2015-05-19       Impact factor: 4.241

10.  Renal expression and urinary excretion of liver-type fatty acid-binding protein in cats with renal disease.

Authors:  Masaaki Katayama; Keiichi Ohata; Tamako Miyazaki; Rieko Katayama; Nobuko Wakamatsu; Misa Ohno; Tetsuro Yamashita; Tsuyoshi Oikawa; Takeshi Sugaya; Masao Miyazaki
Journal:  J Vet Intern Med       Date:  2020-02-22       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.